Search Results - "Hatzioannou, A"

Balancing cancer immunotherapy and immune-related adverse events: The emerging role of regulatory T cells by Alissafi, T., Hatzioannou, A., Legaki, A.I., Varveri, A., Verginis, Panayotis

“…Advances in our understanding οf tumor immunity have prompted a paradigm shift in oncology, with the emergence of immunotherapy, where therapeutic agents are…”
Get full text

Effect of Advanced Glycation End Products on Human Thyroglobulin's Antigenicity as Identified by the Use of Sera from Patients with Hashimoto's Thyroiditis and Gestational Diabetes Mellitus by Alevizaki, Maria, Sarantopoulou, V., Peppa, Melpomeni, Anastasiou, E., Mantzou, Emily, Kanistras, I., Hatzioannou, A., Lymberi, P.

“…Advanced glycation end products (AGEs) are formed on proteins after exposure to high concentrations of glucose and modify protein’s immunogenicity. Herein, we…”
Get full text

Suppressive effect of an embryo-derived factor to pathogenic T-cells causing thyroid autoimmunity by Hatzioannou, A, Bobou, G, Lymberi, P, Barnea, E

Get full text

Evaluation of the therapeutic response to In-111-DTPA octreotide-based targeted therapy in liver metastatic neuroendocrine tumors according to CT/MRI/US findings by Limouris, Georgios Spyridon, Dimitropoulos, Nikolaos, Kontogeorgakos, Dimitrios, Papanikolos, Georgios, Koutoulidis, Vassilios, Hatzioannou, Achilleas, Mourikis, Dimitrios, Lyra, Maria, Dimitriou, Panagiotis, Stravaka, Anastasia, Vlahos, Lambros

“…Thirteen (13) patients with liver neuroendocrine carcinomas metastases, positive for somatostatin receptors, confirmed by scintigraphy were infused with…”
Get more information

Auger-electron therapeutic effectiveness in neuro-endocrine and non-tumors using indium-111 labelled pentetreotide by Limouris, G. S., Voliotopoulos, V., Dimitropoulos, N., Shukla, S. K., Schillaci, O., Scopinaro, F., Hatzioannou, A., Gouliamos, A., Kondi-Pafiti, A., Stavraka-Kakavaki, A., Vlachos, L.

Get full text